COVINGTON & BURLING LLP for JOHNSON & JOHNSON SERVICES INC
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Energy and Commerce Bipartisan Discussion Draft legislation to modernize regulatory framework for cosmetics and personal care products, Cosmetic Safety Enhancement Act of 2019 (H.R. 5279), Division B- Over the Counter Monograph Safety, Innovation and Reform provisions of The Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019 (H.R. 269), Children's Products Warning Label Act of 2019 (H.R. 1816)
| Lobbyist | Covered position, as disclosed |
|---|---|
| WADE ACKERMAN | — |
| GARY HEIMBERG | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.